Tuesday, December 20, 2016

Investors see Biogen CEO choice as friendly to potential takeover

NEW YORK, Dec 20 (Reuters) - The surprise selection of

Michel Vounatsos to run Biogen Inc signals a shift

toward a more commercial management focus after years of

targeting ambitious scientific...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)